{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:38:45Z","timestamp":1790242725779,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1124\/dmd.105.005314","type":"journal-article","created":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T00:33:41Z","timestamp":1122510821000},"page":"1576-1579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["INTERACTION OF PROGESTINS WITH THE HUMAN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2)"],"prefix":"10.1016","volume":"33","author":[{"given":"Heike","family":"Lindenmaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Emil","family":"Haefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.105.005314_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-2952(02)01015-8","article-title":"Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate.","volume":"64","author":"Bode","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.105.005314_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jps.10395","article-title":"The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins.","volume":"92","author":"Bogman","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.105.005314_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0773.2001.890304.x","article-title":"Cholestasis and regulation of genes related to drug metabolism biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin).","volume":"89","author":"Bramow","year":"2001","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/dmd.105.005314_bib4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1067\/mcp.2002.128388","article-title":"Sex-related differences in the clearance of cytochrome P4503A4 substrates may be caused by P-glycoprotein.","volume":"72","author":"Cummins","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.105.005314_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-2952(00)00535-9","article-title":"Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. Multidrug transporters in the LLC-PK (1) cell line and its resistant counterpart.","volume":"61","author":"Decorti","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.105.005314_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1054\/bjoc.2000.1260","article-title":"Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.","volume":"83","author":"Evers","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.105.005314_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI928","article-title":"Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.","volume":"101","author":"Evers","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1124\/dmd.105.005314_bib8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1172\/JCI118535","article-title":"Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.","volume":"98","author":"Evers","year":"1996","journal-title":"J Clin Investig"},{"key":"10.1124\/dmd.105.005314_bib9","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.bcp.2004.08.026","article-title":"In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins.","volume":"68","author":"Fr\u00f6hlich","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.105.005314_bib10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9440(10)64794-3","article-title":"The effect of rifampin treatment on intestinal expression of human MRP transporters.","volume":"157","author":"Fromm","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1124\/dmd.105.005314_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.102.035014","article-title":"Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition.","volume":"302","author":"Gerk","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.105.005314_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","article-title":"Carbamazepine regulates intestinal P-glycoprotein and multi drug resistance protein MRP2 and influences disposition of talinolol in humans.","volume":"76","author":"Giessmann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.105.005314_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2002-24241","article-title":"Trends of OC use 1980\u20131999 in a German cohort of women.","volume":"124","author":"Heinemann","year":"2002","journal-title":"Zentralbl Gynakol"},{"key":"10.1124\/dmd.105.005314_bib14","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1097\/00002030-200211220-00009","article-title":"Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors and transport can be enhanced by other drugs.","volume":"16","author":"Huisman","year":"2002","journal-title":"AIDS"},{"key":"10.1124\/dmd.105.005314_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0968-0004(92)90489-V","article-title":"The ATP-dependent glutathione S-conjugate export pump.","volume":"17","author":"Ishikawa","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/dmd.105.005314_bib16","first-page":"G16","article-title":"Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR.","volume":"272","author":"Ito","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.105.005314_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestogens.","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"key":"10.1124\/dmd.105.005314_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1248\/bpb.22.535","article-title":"Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine.","volume":"22","author":"Nakayama","year":"1999","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.105.005314_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ijc.1498","article-title":"Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.","volume":"94","author":"Nies","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1124\/dmd.105.005314_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199601253340405","article-title":"Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.","volume":"334","author":"Norris","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.105.005314_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s001090050127","article-title":"The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man.","volume":"75","author":"Paulusma","year":"1997","journal-title":"J Mol Med"},{"key":"10.1124\/dmd.105.005314_bib22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.V881213","article-title":"Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules.","volume":"8","author":"Schaub","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/dmd.105.005314_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.105.005314_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0773.1998.tb01395.x","article-title":"Tissue distribution of sex steroids: concentration of 17\u03b2-oestradiol and cyproterone acetate in selected organs of female Wistar rats.","volume":"82","author":"Schleicher","year":"1998","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/dmd.105.005314_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0010-7824(76)90083-4","article-title":"Bio-availability and pharmacokinetics of cyproterone acetate and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB).","volume":"14","author":"Speck","year":"1976","journal-title":"Contraception"},{"key":"10.1124\/dmd.105.005314_bib26","first-page":"R1495","article-title":"Expression of members of the multidrug resistance protein family in human term placenta.","volume":"279","author":"St.-Pierre","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.105.005314_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-2001-17036","article-title":"German Cohort Study on Women\u2019s Health. Reasons for the change in HRT therapy from the perspective of women. Results of the German Cohort Study on Women\u2019s Health.","volume":"123","author":"Thiel","year":"2001","journal-title":"Zentralbl Gynakol"},{"key":"10.1124\/dmd.105.005314_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00221-003-1620-4","article-title":"Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions.","volume":"153","author":"T\u00f6r\u00f6k","year":"2003","journal-title":"Exp Brain Res"},{"key":"10.1124\/dmd.105.005314_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants.","volume":"305","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.105.005314_bib30","first-page":"1798","article-title":"Multidrug resistance proteins MRP3, MRP1 and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.","volume":"7","author":"Young","year":"2001","journal-title":"Clin Cancer Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624033014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624033014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.105.005314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:55:16Z","timestamp":1739901316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624033014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0090955624033014"],"URL":"https:\/\/doi.org\/10.1124\/dmd.105.005314","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"INTERACTION OF PROGESTINS WITH THE HUMAN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2)","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.105.005314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}